Diaceutics PLC
DXRX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£2,401 | £881 | -£2,584 | -£261 |
| Dep. & Amort. | £2,701 | £2,352 | £2,275 | £2,147 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £425 | £628 | £0 | £357 |
| Change in WC | £3,863 | -£6,292 | £2,842 | -£1,320 |
| Other Non-Cash | -£3,788 | £1,930 | -£1,032 | -£310 |
| Operating Cash Flow | £605 | -£501 | £1,501 | £613 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£55 | -£39 | -£1,446 | -£64 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£2,767 | -£2,895 | £0 | -£1,452 |
| Investing Cash Flow | -£2,822 | -£2,934 | -£1,446 | -£1,516 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£141 | £0 | -£98 | £13 |
| Stock Issued | £0 | £1 | £135 | £0 |
| Stock Repurch. | £0 | £0 | £0 | -£19 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | -£102 | £0 | -£92 |
| Financing Cash Flow | -£141 | -£101 | £37 | -£98 |
| Forex Effect | -£197 | -£469 | -£10 | -£212 |
| Net Chg. in Cash | -£2,360 | -£4,005 | £82 | -£1,213 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £12,744 | £16,749 | £16,667 | £17,880 |
| End Cash | £10,384 | £12,744 | £16,749 | £16,667 |
| Free Cash Flow | £550 | -£540 | £1,440 | £549 |